Author:
De Vleeschauwer Annebel R.,Baras Benoît,Kyriakis Constantinos S.,Jacob Valérie,Planty Camille,Giannini Sandra L.,Mossman Sally,Van Reeth Kristien
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference34 articles.
1. World Health Organisation (WHO). Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO; 2003–2012. Available at: http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/index.html.
2. H5N1 viruses and vaccines;Subbarao;PLoS Pathog,2007
3. Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data;Leroux-Roels;Expert Opin Biol Ther,2009
4. European Medicines Agency (EMEA). Prepandrix. GlaxoSmithKline Biologicals SA, Rixensart, Belgium. Available at: http://www.emea.europa.eu/pdfs/human/opinion/Prepandrix_33405509en.pdf or http://www.emea.europa.eu/humandocs/Humans/EPAR/prepandrix/prepandrix.htm.
5. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial;Leroux-Roels;Lancet,2007
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献